Muscular Dystrophy-Dystroglycanopathy (Congenital With Mental Retardation), Type B, 1
MDDGB1

Contact us
 
Return to database




Prevalence (%) of clinical parameters based on data from 1 references describing 5 individuals







Add new symptom/sign to this disease

Select symptom from list or write it in the box
Pubmed id number as a reference Organ system affected
Number of patients in the reference Percent affected patients (Between 0 and 1, eg. 0.1 = 10%)
Please provide your name and contact information as a reference
Name Institute Phone number Email address


List of symptoms



Symptom/sign Organ system Percent affected Pubmed id Added on(yyyy-mm-dd) Edit/add reference
Calf hypertrophy skeletal 100 % 16575835 2024-05-09
Elevated creatine kinase (CK) levels circulatory 100 % 16575835 2024-05-09
Microcephaly nervous 100 % 16575835 2024-05-09
non-walking multi 100 % 16575835 2024-05-09
Mental retardation nervous 100 % 16575835 2024-05-09
Cerebellum hypoplasia nervous 100 % 16575835 2024-05-09
Cortical dysgenesis nervous 60 % 16575835 2024-05-09
Myopia nervous 60 % 16575835 2024-05-09
Hydrocephalus nervous 60 % 16575835 2024-05-09
Fusion of hemispheres nervous 20 % 16575835 2024-05-09
Corpus callosum thining nervous 20 % 16575835 2024-05-09
Septum pellucidum defect nervous 20 % 16575835 2024-05-09



List of references:


The expanding phenotype of POMT1 mutations: from Walker-Warburg syndrome to congenital muscular dystrophy, microcephaly, and mental retardation.
Jeroen van Reeuwijk, Svetlana Maugenre, Christa van den Elzen, Aad Verrips, Enrico Bertini, Francesco Muntoni, Luciano Merlini, Hans Scheffer, Han G Brunner, Pascale Guicheney, Hans van Bokhoven,



Human mutation - May 2006